Patient assessment and differential diagnosis of eyelid and conjunctival lesions
An overview of eyelid lesions, both benign and malignant that may present to an eye care practitioner. Recognising patterns of various lesions to help make a spot diagnosis.
Recognition of common benign lid and conjunctival lesions
Recognition of malignant eyelid and conjunctival lesions
Differentiating between benign and malignant eyelid and conjunctival lesions
Medical and surgical treatment options in eyelid and conjunctival malignant lesions
Therapeutic – Yes
Red flag signs of periocular skin cancer:
Distorted eyelid anatomy
Loss of the Grey Line
Management options in periocular skin cancer
The periocular area is a high risk site and surgical management is the preferred option in the vast majority of cases. A biopsy confirming the diagnosis is often performed prior to reconstructive surgery with margin control. Techniques from simple closure to reconstruction of more extensive defects will be discussed.
Skin cancer statistics and prevention
The most common skin cancer is the basal cell carcinoma (BCC). Over 75% percent of BCCs occur in the head and neck region. At about 20% of BBC appear in periocular region
Within the Periocular region – 50% lower lid, 30% medial canthus, 15% upper lid, 5% lateral canthus.
Approximately 40% of patients who have had one BCC will develop another lesion within five years.